Suchergebnisse - "Higashi-Kuwata, Nobuyo"

PubPharm (44)

1

A lipid index for risk of hyperlipidemia caused by anti-retroviral drugs

enthalten in: Antiviral research | 2024

von Shimura, M. | Higashi-Kuwata, N. | Fujiwara, A. | +11

2

Exploration of P1 and P4 modifications of nirmatrelvir : Design, synthesis, biological evaluation, and X-ray structural studies of SARS-CoV-2 Mpro inhibitors

enthalten in: European journal of medicinal chemistry | 2024

von Ghosh, A. | Yadav, M. | Iddum, S. | +10

3

Exploratory Studies on Amide Bond Replacement of a SARS-CoV-2 Main Protease Inhibitor Utilizing a Chloroalkene Dipeptide Isostere

enthalten in: ResearchSquare.com | 2024

von Kobayakawa, T. | Azuma, C. | Higashi-Kuwata, N. | +6

4

SARS-CoV-2 papain-like protease (PLpro) inhibitory and antiviral activity of small molecule derivatives for drug leads

enthalten in: Bioorganic & medicinal chemistry letters | 2023

von Ghosh, A. | Shahabi, D. | Imhoff, M. | +6

5

Neutralization against Omicron sublineages (BA.2/BA.5/BQ.1.1/XBB/XBB.1.5) in bivalent BNT162b2-vaccinated HCWs with or without risk factors, or following BT infection with Omicron

enthalten in: ResearchSquare.com | 2023

von Amano, M. | Otsu, S. | Uemura, Y. | +6

6

Neutralization against Omicron sublineages (BA.2/BA.5/BQ.1.1/XBB/XBB.1.5) in bivalent BNT162b2-vaccinated HCWs with or without risk factors, or following BT infection with Omicron

enthalten in: Scientific reports | 2023

von Amano, M. | Otsu, S. | Uemura, Y. | +6

7

Structure-Activity Relationship Studies of SARS-CoV-2 Main Protease Inhibitors Containing 4-Fluorobenzothiazole-2-carbonyl Moieties

enthalten in: Journal of medicinal chemistry | 2023

von Tsuji, K. | Ishii, T. | Kobayakawa, T. | +10

8

GRL-142 binds to and impairs HIV-1 integrase nuclear localization signal and potently suppresses highly INSTI-resistant HIV-1 variants

enthalten in: Science advances | 2023

von Aoki, M. | Aoki-Ogata, H. | Bulut, H. | +18

9

Synthesis of novel entecavir analogues having 4'-cyano-6''-fluoromethylenecyclopentene skeletons as an aglycone moiety as highly potent and long-acting anti-hepatitis B virus agent

enthalten in: RSC advances | 2023

von Kumamoto, H. | Higashi-Kuwata, N. | Hayashi, S. | +11

10

A novel anti-HBV agent, E-CFCP, restores Hepatitis B virus (HBV)-induced senescence-associated cellular marker perturbation in human hepatocytes

enthalten in: Virus research | 2023

von Takamatsu, Y. | Hayashi, S. | Kumamoto, H. | +4

1
2
3
4
5
Nächster »
[5]